Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon IR Dose-Ranging Study in CF-related PEI
NCT02415959Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2015
- Primary completion
- Jul 2015
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of LipaCreon in pancreatic exocrine insufficiency (EPI), sponsored by Abbott Laboratories. Started Mar 2015; status: completed.
02
Drugs
LipaCreon
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT02415959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415959.